Europe · Macro, forex & crypto · Sharecast
Germany's Merck to snap up Silence Therapeutics in $1.3bn deal
Shares in Silence Therapeutics more than doubled on Monday, after the US-listed British biotech agreed to be taken over by Germany’s Merck in a $1.3bn deal.
Read the full article on Sharecast Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.sharecast.com)